NURS FPX 6021 Assessment 2 Justification of the Proposed Change Strategies for the Improvement of Safety and Provision of Equitable Care 

 

In the presence of the Polycystic ovarian syndrome PCOS, there is no universal treatment that can help pateints to reduce panic attacks. This increases their depression in a severe way and also lowers the motivation and morale of patients to remain physically fit. PCOS create weight gain challenges which can give rise to cardiovascular diseases. Luckily, the use of the CBT will help achieve the desired outcomes to help the patient improve their physical and mental states. The efficient healthcare provisions suggest that group therapy is conducted by providing individual sessions to the patient. The CBT has helped to provide them the group therapy and facilitated wither wellbeing to reduce depression, anxiety, and hypertension symptoms.  

Change Strategy and Implementation KG

How Change Strategies Will Lead to Quality Improvement

In addition to the CBT, some pharmacological interventions are also viable in this scenario to achieve desired outcomes. Due to severity of mental disorder, treatments can differ. Doctors should however refrain from using complicated antidepressants and should use tricyclic antidepressants. Use of Benzodiazepines should be carefully done for treating PCOS and COPD patients to save them from tremors and headaches.  Using these interventions collectively, the depression and anxiety interventions will meet the needs of individual patients.  The interprofessional collaboration change strategy will help to ensure successful implementation. The proposed strategies will be successful; the professionals must use collaborative techniques such as coordinated communication during breaks and sharing their ideas and problems to improve coordination between therapists, nurses, and pharmacologists.  

References 

Khan, M. J., Ullah, A., & Basit, S. (2019). Genetic basis of polycystic ovary syndrome (PCOS): Current perspectives. The Application of Clinical Genetics, 12, 249–260. https://doi.org/10.2147/TACG.S200341

Kyrou, I., Karteris, E., Robbins, T., Chatha, K., Drenos, F., &Randeva, H. S. (2020). Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic. BMC Medicine, 18(1), 220. https://doi.org/10.1186/s12916-020-01697